Literature DB >> 30043506

The role of 5-hydroxymethylcytosine in mitochondria after ischemic stroke.

Feng Ji1, Chenyu Zhao2, Bin Wang1, Yan Tang1, Zhigang Miao1, Yongxiang Wang3,4.   

Abstract

5-Hydroxymethylcytosine (5hmC) exists in DNA, RNA, and mitochondrial DNA (mtDNA) and plays an important role in many diseases. Specifically, 5hmC is involved in promoting gene expression, and this process is regulated by Tet enzymes. In this study, we identified that there is no difference in male mice and female mice at first; then we examined the levels of 5hmC in mtDNA and explored the relationship among 5hmC, mitochondrial gene expression and ATP production after acute brain ischemia. The abundance of mtDNA 5hmC was increased at 1 d and peaked at 2 d after ischemic injury, whereas that of mtDNA 5mC was unchanged. Furthermore, increased mitochondrial Tet2 expression was found to be responsible for the increase in mtDNA 5hmC. Tet2 inhibition decreased the mtDNA 5hmC abundance and increased the ATP levels in mitochondria, suggesting an association between the cellular ATP levels and mtDNA 5hmC abundance. We also demonstrated that mtDNA 5hmC increased the mRNA levels of mitochondrial genes after ischemia/reperfusion (I/R) injury.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  5-hydroxymethylcytosine; ATP; Tet2; middle cerebral artery occlusion; mitochondria

Mesh:

Substances:

Year:  2018        PMID: 30043506     DOI: 10.1002/jnr.24274

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  8 in total

Review 1.  Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

Authors:  Mario J Bertogliat; Kahlilia C Morris-Blanco; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2019-12-12       Impact factor: 3.921

Review 2.  Tet Enzymes-Mediated DNA 5hmC Modification in Cerebral Ischemic and Hemorrhagic Injury.

Authors:  Xiaohua Ma; Bo Yang; Xiaojing Li; Zhigang Miao
Journal:  Neurotox Res       Date:  2022-04-08       Impact factor: 3.911

Review 3.  Epigenetic mechanisms and potential therapeutic targets in stroke.

Authors:  Kahlilia C Morris-Blanco; Anil K Chokkalla; Vijay Arruri; Soomin Jeong; Samantha M Probelsky; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2022-07-19       Impact factor: 6.960

4.  Intermittent hypoxia promotes the recovery of motor function in rats with cerebral ischemia by regulating mitochondrial function.

Authors:  Yue Su; Changkai Ke; Chen Li; Chuan Huang; Chunxiao Wan
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

5.  Epigenetic Modifications in Peripheral Blood as Potential Noninvasive Biomarker of Diabetic Retinopathy.

Authors:  Arul J Duraisamy; Rakesh Radhakrishnan; Berhane Seyoum; Gary W Abrams; Renu A Kowluru
Journal:  Transl Vis Sci Technol       Date:  2019-12-18       Impact factor: 3.283

Review 6.  Mitochondrial metabolism and DNA methylation: a review of the interaction between two genomes.

Authors:  Amanda F C Lopes
Journal:  Clin Epigenetics       Date:  2020-11-23       Impact factor: 6.551

7.  β2SP/TET2 complex regulates gene 5hmC modification after cerebral ischemia.

Authors:  Xiaohua Ma; Meng Zhang; Rui Yan; Hainan Wu; Bo Yang; Zhigang Miao
Journal:  J Cell Mol Med       Date:  2021-11-19       Impact factor: 5.310

Review 8.  Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies.

Authors:  Ibolya Czegle; Austin L Gray; Minjing Wang; Yan Liu; Jun Wang; Edina A Wappler-Guzzetta
Journal:  Life (Basel)       Date:  2021-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.